EUVIMEDEUVIMED entdecken
Crossref

Impact of a pharmacist-led breast cancer clinic on oncology consultant workload and patient experience in a UK cancer centre

Mr Michal Sladkowski iD

Journal of Oncology Pharmacy Practice · 12.06.2026

DOI: 10.1177/10781552261459918 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oncology Pharmacy Practice, online erschienen am 12.06.2026. Verfasst von Mr Michal Sladkowski. Beteiligte Einrichtung: Oncology, York and Scarborough Teaching Hospitals NHS foundation trust, York, UK of Great Britain and Northern Ireland. Die Arbeit nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

UK oncology services face increasing demand alongside workforce constraints. This study evaluated the impact of a pharmacist-led breast cancer clinic on consultant workload and clinic utilisation in a UK district general hospital.

Methods

This was a prospective service evaluation conducted over 11 months following implementation of an independent prescribing pharmacist-led breast cancer clinic. Data were collected on systemic anti-cancer therapy (SACT) prescribing, clinic overbooking rates, and pharmacist-led consultations, including requirement for consultant input.

Results

The pharmacist prescribed 420 of 3135 (13.4%) of all breast cancer systemic anti-cancer prescriptions (95% CI: 12.2%–14.6%). Pharmacist consultations were conducted independently in 81.5% (95% CI: 77.7%–85.3%) of cases, without requiring consultant input. Following implementation, clinic overbooking rates remained stable (19.6% vs 21.7%; χ 2 = 1.783, p = 0.18), suggesting sustained utilisation of clinic capacity despite redistribution of patient care to pharmacist-led consultations. Requirement for medical input differed according to treatment type (χ 2 = 11.8, p < 0.001), consistent with anticipated differences in treatment complexity and clinical oversight requirements.

Conclusion

The pharmacist-led breast cancer clinic absorbed a significant proportion of routine prescribing and reviews of breast cancer patients, with the majority of consultations managed independently. Broader adoption of this approach may support redistribution of workload and maintenance of clinic capacity within oncology services. Further work is required to evaluate safety outcomes and cost-effectiveness.

Schlagwörter

Stichwörter der Autor:innen

Breast canceroncologypharmacist

Autor:innen und Institutionen

  • Oncology, York and Scarborough Teaching Hospitals NHS foundation trust, York, UK of Great Britain and Northern Ireland.

ORCID-Profile: Mr Michal Sladkowski

Zitieren

APA

Sladkowski, M. M. (2026). Impact of a pharmacist-led breast cancer clinic on oncology consultant workload and patient experience in a UK cancer centre. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552261459918

Vancouver

Sladkowski MM. Impact of a pharmacist-led breast cancer clinic on oncology consultant workload and patient experience in a UK cancer centre. Journal of Oncology Pharmacy Practice. 2026. doi:10.1177/10781552261459918

BibTeX
@article{Sladkowski2026,
  author = {Sladkowski, Mr Michal},
  title = {Impact of a pharmacist-led breast cancer clinic on oncology consultant workload and patient experience in a UK cancer centre},
  journal = {Journal of Oncology Pharmacy Practice},
  year = {2026},
  doi = {10.1177/10781552261459918}
}
Kostenlos starten →